Brazil Veterinary Regenerative Medicine Market Size & Outlook
Brazil veterinary regenerative medicine market, 2018-2030 (US$M)
Related Markets
Brazil veterinary regenerative medicine market highlights
- The Brazil veterinary regenerative medicine market generated a revenue of USD 3.8 million in 2022 and is expected to reach USD 9.0 million by 2030.
- The Brazil market is expected to grow at a CAGR of 11.4% from 2023 to 2030.
- In terms of segment, stem cells was the largest revenue generating product in 2022.
- Other Products is the most lucrative product segment registering the fastest growth during the forecast period.
Veterinary regenerative medicine market data book summary
| Market revenue in 2022 | USD 3.8 million |
| Market revenue in 2030 | USD 9.0 million |
| Growth rate | 11.4% (CAGR from 2022 to 2030) |
| Largest segment | Stem cells |
| Fastest growing segment | Other Products |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Stem cells, Other Products |
| Key market players worldwide | Boehringer Ingelheim, Zoetis Inc Class A, Dechra Pharmaceuticals, Integra Lifesciences Holdings Corp, Ardent Health Services, Vetherapy, VET-STEM INC., Enso Discoveries, Animal Cell Therapies |
Other key industry trends
- In terms of revenue, Brazil accounted for 2.3% of the global veterinary regenerative medicine market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil veterinary regenerative medicine market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 9.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Regenerative Medicine Market Scope
Veterinary Regenerative Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil veterinary regenerative medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary regenerative medicine market will help companies and investors design strategic landscapes.
Stem cells was the largest segment with a revenue share of 52.63% in 2022. Horizon Databook has segmented the Brazil veterinary regenerative medicine market based on stem cells, other products covering the revenue growth of each sub-segment from 2018 to 2030.
In August 2022, Ourofino Sade Animal anticipates increasing investments in the pet market to increase revenue, according to a GlobalPETS article. NeoStem is intended to help dogs with disorders such as osteoarthritis, conjunctivitis sicca, and distemper sequelae.
To preserve the quality of the cells, they are taken from young animals up to 2 years old. The Brazilian Federal Council of Veterinary Medicine regulated the use of stem cells in animals in 2021. The Brazilian company expects to widely promote this treatment throughout Latin America in the upcoming years.
Reasons to subscribe to Brazil veterinary regenerative medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil veterinary regenerative medicine market databook
-
Our clientele includes a mix of veterinary regenerative medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil veterinary regenerative medicine market , including forecasts for subscribers. This country databook contains high-level insights into Brazil veterinary regenerative medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil veterinary regenerative medicine market size, by product, 2018-2030 (US$M)
Brazil Veterinary Regenerative Medicine Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
